Key Takeaways
- • Permira secures A$3.4 billion exit from I-MED Radiology, marking a significant capital return from the Australian diagnostic imaging portfolio company.
- • Bowmark Capital and Bridgepoint sell Helio Intelligence to ECI Partners; Toby Fitzherbert (ECI investment director) characterizes Helio as "the go-to provider of political intelligence and monitoring services across Europe," signaling strategic value in European political risk and compliance monitoring.
- • Oakley Capital acquires XTEL stake from dual sellers Bain Capital and SilverTree Partners, consolidating ownership in the telecommunications or technology infrastructure asset.
- • Three separate mid-market PE transactions reflect active secondary market activity and LP capital deployment across healthcare services, intelligence/compliance, and infrastructure sectors.
Summary
Three significant private equity transactions closed in late May 2026, reflecting continued activity in secondary markets and strategic asset rotations among leading alternative investment managers.
Permira completed its exit from I-MED Radiology at an A$3.4 billion valuation, representing a full or partial capital return from the Australian diagnostic imaging services platform. The transaction marks a milestone exit for Permira's healthcare services portfolio and reflects ongoing consolidation in the medical imaging sector.
In a separate transaction, Bowmark Capital and Bridgepoint Partners divested Helio Intelligence to ECI Partners. Toby Fitzherbert, investment director at ECI, underscored the asset's strategic positioning: "Helio has built an impressive position as the go-to provider of political intelligence and monitoring services across Europe." The acquisition by ECI signals growing institutional demand for compliance, political risk monitoring, and regulatory intelligence capabilities—particularly relevant given rising geopolitical complexity and ESG-related transparency requirements across European markets.
Oakley Capital acquired a stake in XTEL from co-sellers Bain Capital and SilverTree Partners. The transaction reflects typical secondary market dynamics where incumbent sponsors exit positions to redeploy capital elsewhere in their portfolios.
Collectively, these three transactions underscore sustained dealmaking velocity in mid-market PE despite macroeconomic volatility, with sponsors targeting exits through strategic buyer acquisitions and secondary placements.
Permira completed its exit from I-MED Radiology at an A$3.4 billion valuation, representing a full or partial capital return from the Australian diagnostic imaging services platform. The transaction marks a milestone exit for Permira's healthcare services portfolio and reflects ongoing consolidation in the medical imaging sector.
In a separate transaction, Bowmark Capital and Bridgepoint Partners divested Helio Intelligence to ECI Partners. Toby Fitzherbert, investment director at ECI, underscored the asset's strategic positioning: "Helio has built an impressive position as the go-to provider of political intelligence and monitoring services across Europe." The acquisition by ECI signals growing institutional demand for compliance, political risk monitoring, and regulatory intelligence capabilities—particularly relevant given rising geopolitical complexity and ESG-related transparency requirements across European markets.
Oakley Capital acquired a stake in XTEL from co-sellers Bain Capital and SilverTree Partners. The transaction reflects typical secondary market dynamics where incumbent sponsors exit positions to redeploy capital elsewhere in their portfolios.
Collectively, these three transactions underscore sustained dealmaking velocity in mid-market PE despite macroeconomic volatility, with sponsors targeting exits through strategic buyer acquisitions and secondary placements.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.